GS-101 Antisense Oligonucleotide Eye Drops Inhibit Corneal Neovascularization

Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels

Christian Fischer, Bart Jonckx, Massimiliano Mazzone et al. · Cell · 2007 · 786 citations · Full text

Tumor Biology, Angiogenesis, Medicine +10

Risk Factors for Corneal Graft Failure and Rejection in the Collaborative Corneal Transplantation Studies

Maureen G. Maguire, Walter J. Stark, John D. Gottsch et al. · Ophthalmology · 1994 · 464 citations

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.

Shiro Amano, Richard M. Rohan, Manabu Kuroki et al. · PubMed · 1998 · 338 citations

Inhibition of Hemangiogenesis and Lymphangiogenesis<i>after</i>Normal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

Claus Cursiefen, Jingtai Cao, Lu Chen et al. · Investigative Ophthalmology & Visual Science · 2004 · 328 citations · Full text

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Felix Bock, Jasmine Onderka, Tina Dietrich-Ntoukas et al. · Investigative Ophthalmology & Visual Science · 2007 · 319 citations · Full text